Guilin Sanjin Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 14.80%

Guilin Sanjin Pharmaceutical Co Ltd (002275) has an Asset Resilience Ratio of 14.80% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how liquid is Guilin Sanjin Pharmaceutical Co Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥636.30 Million

≈ $93.11 Million USD Cash + Short-term Investments

Total Assets

CN¥4.30 Billion

≈ $629.19 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2010–2024)

This chart shows how Guilin Sanjin Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Guilin Sanjin Pharmaceutical Co Ltd asset portfolio.

Liquid Assets Composition Over Time

This chart breaks down Guilin Sanjin Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore investment intensity of Guilin Sanjin Pharmaceutical Co Ltd to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥636.30 Million	14.8%
Total Liquid Assets	CN¥636.30 Million	14.80%

Asset Resilience Insights

Moderate Liquidity: Guilin Sanjin Pharmaceutical Co Ltd has 14.80% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Guilin Sanjin Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Guilin Sanjin Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Beijing Tongrentang Co Ltd SHG:600085	Drug Manufacturers - Specialty & Generic	0.50%
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Neuland Laboratories Limited NSE:NEULANDLAB	Drug Manufacturers - Specialty & Generic	9.65%
China Resources Double-Crane Pharmaceutical Co Ltd SHG:600062	Drug Manufacturers - Specialty & Generic	1.18%
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	Drug Manufacturers - Specialty & Generic	0.01%

Annual Asset Resilience Ratio for Guilin Sanjin Pharmaceutical Co Ltd (2010–2024)

The table below shows the annual Asset Resilience Ratio data for Guilin Sanjin Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	14.79%	CN¥626.15 Million ≈ $91.62 Million	CN¥4.23 Billion ≈ $619.31 Million	+7.05pp
2023-12-31	7.74%	CN¥304.69 Million ≈ $44.59 Million	CN¥3.94 Billion ≈ $575.97 Million	+3.67pp
2022-12-31	4.07%	CN¥161.24 Million ≈ $23.59 Million	CN¥3.96 Billion ≈ $580.19 Million	-1.35pp
2021-12-31	5.41%	CN¥221.77 Million ≈ $32.45 Million	CN¥4.10 Billion ≈ $599.35 Million	-3.74pp
2020-12-31	9.15%	CN¥355.34 Million ≈ $52.00 Million	CN¥3.88 Billion ≈ $568.10 Million	+7.18pp
2019-12-31	1.98%	CN¥67.50 Million ≈ $9.88 Million	CN¥3.42 Billion ≈ $499.81 Million	+1.98pp
2018-12-31	0.00%	CN¥1.27K ≈ $186.02	CN¥3.41 Billion ≈ $498.42 Million	-11.29pp
2017-12-31	11.29%	CN¥364.60 Million ≈ $53.35 Million	CN¥3.23 Billion ≈ $472.59 Million	+3.95pp
2016-12-31	7.34%	CN¥210.66 Million ≈ $30.83 Million	CN¥2.87 Billion ≈ $419.95 Million	+3.51pp
2015-12-31	3.83%	CN¥105.60 Million ≈ $15.45 Million	CN¥2.76 Billion ≈ $403.83 Million	-5.15pp
2014-12-31	8.98%	CN¥250.00 Million ≈ $36.58 Million	CN¥2.78 Billion ≈ $407.33 Million	+8.80pp
2010-12-31	0.18%	CN¥3.60 Million ≈ $527.15K	CN¥1.98 Billion ≈ $289.92 Million	--

pp = percentage points

About Guilin Sanjin Pharmaceutical Co Ltd

SHE:002275 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.04 Billion

CN¥7.13 Billion CNY

Market Cap Rank

#8683 Global

#2065 in China

Share Price

CN¥12.14

Change (1 day)

-1.62%

52-Week Range

CN¥12.08 - CN¥15.61

All Time High

CN¥19.61